Pharvaris Bv Stock Beta

PHVS Stock  USD 22.29  1.25  5.94%   
Pharvaris BV fundamentals help investors to digest information that contributes to Pharvaris' financial success or failures. It also enables traders to predict the movement of Pharvaris Stock. The fundamental analysis module provides a way to measure Pharvaris' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharvaris stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Pharvaris BV Company Beta Analysis

Pharvaris' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current Pharvaris Beta

    
  -3.14  
Most of Pharvaris' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharvaris BV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Pharvaris Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Pharvaris is extremely important. It helps to project a fair market value of Pharvaris Stock properly, considering its historical fundamentals such as Beta. Since Pharvaris' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pharvaris' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pharvaris' interrelated accounts and indicators.
1.0-1.0-0.970.640.970.761.01.01.00.970.810.970.950.84-0.85-0.85
1.0-1.0-0.970.630.970.751.01.01.00.970.810.970.940.83-0.85-0.85
-1.0-1.00.97-0.65-0.97-0.78-1.0-1.0-1.0-0.97-0.83-0.97-0.94-0.840.820.82
-0.97-0.970.97-0.75-0.91-0.84-0.97-0.97-0.97-0.97-0.78-0.97-0.98-0.940.820.82
0.640.63-0.65-0.750.590.960.630.640.620.750.790.750.830.83-0.3-0.3
0.970.97-0.97-0.910.590.730.970.970.970.910.850.910.870.73-0.78-0.78
0.760.75-0.78-0.840.960.730.750.760.750.820.860.820.880.88-0.4-0.4
1.01.0-1.0-0.970.630.970.751.01.00.970.810.970.940.83-0.85-0.85
1.01.0-1.0-0.970.640.970.761.01.00.970.810.970.950.84-0.85-0.85
1.01.0-1.0-0.970.620.970.751.01.00.970.810.970.940.83-0.85-0.85
0.970.97-0.97-0.970.750.910.820.970.970.970.841.00.980.88-0.79-0.79
0.810.81-0.83-0.780.790.850.860.810.810.810.840.840.810.65-0.39-0.39
0.970.97-0.97-0.970.750.910.820.970.970.971.00.840.980.88-0.79-0.79
0.950.94-0.94-0.980.830.870.880.940.950.940.980.810.980.94-0.76-0.76
0.840.83-0.84-0.940.830.730.880.830.840.830.880.650.880.94-0.7-0.7
-0.85-0.850.820.82-0.3-0.78-0.4-0.85-0.85-0.85-0.79-0.39-0.79-0.76-0.71.0
-0.85-0.850.820.82-0.3-0.78-0.4-0.85-0.85-0.85-0.79-0.39-0.79-0.76-0.71.0
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Pharvaris BV has a Beta of -3.145. This is 465.7% lower than that of the Biotechnology sector and notably lower than that of the Health Care industry. The beta for all United States stocks is notably higher than that of the company.

Pharvaris Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharvaris' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pharvaris could also be used in its relative valuation, which is a method of valuing Pharvaris by comparing valuation metrics of similar companies.
Pharvaris is currently under evaluation in beta category among its peers.

Pharvaris ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pharvaris' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pharvaris' managers, analysts, and investors.
Environmental
Governance
Social
As returns on the market increase, returns on owning Pharvaris are expected to decrease by larger amounts. On the other hand, during market turmoil, Pharvaris is expected to outperform it.

Pharvaris Fundamentals

About Pharvaris Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pharvaris BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharvaris using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharvaris BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.